Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells

Peptides

Volumn 18, Issue 6, 1997, Pages 865-868

  Dunlop, John ^a   Zhang, Yingxin ^a   Evans, Non ^b  

^a PFIZER INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Ca2+; CCK 4; CCK 8NS; CCK 8S; CCK A receptor; Microphysiometer; Mobilization; Pentagastrin

Indexed keywords

CHOLECYSTOKININ; PENTAGASTRIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CHEMICAL ANALYSIS; CHO CELL; CHOLECYSTOKININ BLOOD LEVEL; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BENZODIAZEPINONES; BINDING, COMPETITIVE; CALCIUM; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; DEVAZEPIDE; HORMONE ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; PENTAGASTRIN; PEPTIDE FRAGMENTS; PROGLUMIDE; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; TETRAGASTRIN;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0030799423     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00012-0     Document Type: Article

References (18)

1. Bitar N., Makhlouf G. M. Receptors on smooth muscle cells: characterization by contraction and specific antagonists. Am. J. Physiol. 242:1982;G400-G407.
2. Chang R. S. L., Lotti V. J. Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystokinin antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;4923-4926.
3. De Weerth A., Pisegna J. R., Huppi K., Wank S. A. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem. Biophys. Res. Commun. 194:1993;811-818.
4. Denyer J., Gray J., Wolz M., Stolz M., Tate S. Molecular and pharmacological characterization of the human CCK-B receptor. Eur. J. Pharmacol. 268:1994;29-41.
5. Dunlop J., Brammer N., Ennis C. Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene. Neuropeptides. 30:1996;359-363.
6. Dunlop, J.; Brammer, N.; Evans, N.; Ennis, C. YM022 ((R)-1-[2,3-dihydro-1-(2′-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodia zepin-3-yl]-3-(3-methylphenyl)urea): An irreversible cholecystokinin Type-B receptor antagonist. Biochem. Pharmacol. in press.
7. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
8. Hill D. R., Campbell N. J., Shaw T. M., Woodruff G. N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective non-peptide CCK antagonists. J. Neuroscience. 7:1987;2967-2976.
9. Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D. C., Hunter J. C., Pinnock R. D., Woodruff G. N. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc. Natl. Acad. Sci. USA. 87:1990;6728-6732.
10. Innis R. B., Snyder S. H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. USA. 77:1980;6917-6912.
11. Jensen R. T., Wank S. A., Rowley W. H., Sato S., Gardner J. D. Interactions of cholecystokinin with pancreatic acinar cells: A well studied model of peripheral action of CCK. Trends Pharmacol. Sci. 10:1989;418-423.
12. Lee Y.-M., Beinborn M., McBride E. W., Lu M., Kolakowski L. F., Kopin A. S. The human brain cholecystokinin-B/gastrtor. J. Biol. Chem. 268:1993;8164-8169.
13. 2+ concentration in the human JURKAT T lymphocyte cell line. Eur. J. Pharmacol. 245:1993;241-246.
14. Lotti V. J., Chang R. S. L. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor ligand L-365,260. Eur. J. Pharmacol. 162:1989;273-280.
15. McConnell H. M., Owicki J. C., Parce J. W., Miller D. L., Baxter G. T., Wada H. G., Pitchford S. The cytosensor microphysiometer: Biological applications of silicon technology. Science. 257:1992;1906-1912.
16. Nishida A., Miyata K., Tsutsumi R., Yuki H., Akuzawa S., Kobayashi A., Kamato T., Ito H., Yamano M., Katuyama Y., Satoh M., Ohta M., Honda K. Pharmacological profile of YM022, a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther. 269:1994;725-731.
17. Sankaran H., Goldfine I. D., Bailey H., Licko V., Williams J. A. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini. Am. J. Physiol. 242:1982;G250-G257.
18. Woodruff G. N., Hill D. R., Boden P., Pinnock R., Singh L., Hughes J. Functional role of brain CCK receptors. Neuropeptides. 19:((Suppl)):1991;45-56.